Two Bilateral Metal Stenting in Hilar Malignancy
Clinical Outcomes of Endoscopic Bilateral Stent-in-stent Placement Versus Side-by-side Method With Newly Designed Metallic Stent for Malignant Hilar Biliary
1 other identifier
interventional
80
1 country
2
Brief Summary
The overall median survival of nonresectable malignant hilar obstruction in most series has been less than 6 months. Most patients with malignant hilar obstruction present with advanced disease, making allative endoscopic drainage the principal therapeutic option. However, the optimal endoscopic management strategy is contentious. In malignant hilar obstruction, exclusively endoscopic placement of bilateral metal stents has been considered very difficult and complex, and it may require multiple procedures, with an increased risk of complications and mortality. To overcome this difficulty and strategize plan of management, the investigators evaluated the technical and clinical efficacy of endoscopic bilateral placement of newly designed stents, Y-configuration, followed by side-by-side insertion in failure of stent-in-stent method for the management of malignant hilar obstruction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2016
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2010
CompletedFirst Posted
Study publicly available on registry
June 10, 2010
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2018
CompletedDecember 19, 2017
December 1, 2017
2 years
June 8, 2010
December 15, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Technical success
Passage of the double stent across the stricture,along with flow of contrast medium and/or bile through the stent. Adequate expansion: 70% of maximal expanded diameter was dilated within 24 hr.
within 24 hr
Secondary Outcomes (4)
Early complications
within 30 days after stent insertion
Late complications
after 30 days following stent insertion
Median stent patency
up to 1 year, from stent insertion to the occlusion of the stent
Median survival
1 year, from stent insertion to the death of the patient
Study Arms (2)
Bilateral stent-in-stent insertion
EXPERIMENTALThe passage of the bilateral metal stent across the stricture, stent-in-stent method.
Bilateral side-by-side insertion
ACTIVE COMPARATORThe passage of the bilateral metal stent across the stricture, side-by-side method.
Interventions
Following negotiation of both IHD by two guidewires, inserted 1st stent to left IHD side. After deployment of the 1st stent across the hilar stricture, the remaining guide wire across the 1st stent was carefully withdrawn using an ERCP catheter without pulling it back completely. Then that guidewie was inserted under fluoroscopic guidance into the undrained right IHD through the central portion of the 1st stent. The 2nd cross-wired stent was then introduced over a guidewire through the central open mesh and then was deployed into the right IHD, so that the central portion of the 2nd stent overlapped the central portion of the 1st stent, forming a Y-shape.
Following the introduction of two guidewires, the first stent was pushed and deployed into the left hepatic duct as possible, and then subsequently the second stent was pushed and deployed into the right hepatic duct, using the same method. In tight stricture during a guidewire manipulation, pneumatic biliary balloon dilation prior to insertion of first stent was performed. All stents were positioned above the level of the papilla, with their distal ends at the same level as possible. The diameter of the stent used in each case (8 or 10 mm) depended on the maximum diameter of the common bile duct (CBD).
Eligibility Criteria
You may qualify if:
- Patient over 18 years old
- patient with malignant hilar obstruction
You may not qualify if:
- refuse to participate in this study
- refuse to provide informed consent
- Karnofsky score \< 60%
- physically unfit for endoscopic procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Soon Chun Hyang University College of Medicine, Bucheon Hospital
Bucheon-si, 420-767, South Korea
Soon Chun Hyang University College of Medicine, Cheonan Hospital
Cheonan, 330-721, South Korea
Related Publications (1)
Lee TH, Moon JH, Choi JH, Lee SH, Lee YN, Paik WH, Jang DK, Cho BW, Yang JK, Hwangbo Y, Park SH. Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture. Gastrointest Endosc. 2019 Aug;90(2):222-230. doi: 10.1016/j.gie.2019.03.011. Epub 2019 Mar 21.
PMID: 30905729DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jong Ho Moon, MD, PhD
Soon Chun Hyang University College of Medicine, Bucheon Hospital, Bucheon, South Korea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
June 8, 2010
First Posted
June 10, 2010
Study Start
April 1, 2016
Primary Completion
March 30, 2018
Study Completion
September 30, 2018
Last Updated
December 19, 2017
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share